Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

LY75/DEC-205 anticorps (AA 1006-1130)

Cet anticorps Souris Monoclonal détecte spécifiquement LY75/DEC-205 dans IHC (f). Il présente une réactivité envers Humain.
N° du produit ABIN7126649

Aperçu rapide pour LY75/DEC-205 anticorps (AA 1006-1130) (ABIN7126649)

Antigène

Voir toutes LY75/DEC-205 (LY75) Anticorps
LY75/DEC-205 (LY75) (Lymphocyte Antigen 75 (LY75))

Reactivité

  • 55
  • 37
  • 8
  • 8
  • 4
Humain

Hôte

  • 39
  • 30
  • 13
  • 2
  • 1
  • 1
Souris

Clonalité

  • 53
  • 30
  • 2
Monoclonal

Conjugué

  • 36
  • 9
  • 9
  • 8
  • 4
  • 4
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
Cet anticorp LY75/DEC-205 est non-conjugé

Application

  • 34
  • 28
  • 21
  • 20
  • 10
  • 10
  • 8
  • 6
  • 5
  • 4
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
Immunohistochemistry (Formalin-fixed Sections) (IHC (f))
  • Épitope

    • 7
    • 5
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 1006-1130

    Specificité

    DEC-205 (LY75, lymphocyte antigen 75, GP200-MR6) is a 1,695 residue (mature form) multi-lectin receptor that belongs to the MMR (macrophage mannose receptor) family of multidomain molecules. MMR family molecules mediate membrane receptor targeting to endosomes or lysosomes rich in major histocompatibility complex class II (MHC II) products. Expressed in mature dendritic cells (DC), DEC-205 contains an extracellular N-terminal cysteine-rich domain, a fibronectin type II domain, ten C-type carbohydrate recognition domains, a single transmembrane region and a small cytoplasmic C-terminal domain (31 amino acids) containing a tyrosine at 1679. DEC-205 elicits either an agonistic or antagonistic effect on IL-4 function, which is demonstrated by the ability of DEC-205 to imitate IL-4-induced maturation of epithelium or to inhibit IL-4-induced proliferation of T cells, respectively. Acts as an endocytic receptor to direct captured antigens from the extracellular space to a specialized antigen-processing compartment (By similarity). Causes reduced proliferation of B-lymphocytes.

    Réactivité croisée (Details)

    Human.

    Purification

    1.0mg/ml of Ab purified from Bioreactor by Protein A/G.

    Immunogène

    Recombinant fragment (around aa1006-1130) of human LY75 protein (exact sequence is proprietary)

    Isotype

    IgG2b
  • Indications d'application

    Known_Application: Immunohistochemistry (Formalin-fixed) (1-2 μg/mL for 30 minutes at RT),(Staining of formalin-fixed tissues requires heating tissue sections in 10 mM Tris with 1 mM EDTA, pH 9.0, for 45 min at 95 °C followed by cooling at RT for 20 minutes),Optimal dilution for a specific application should be determined.

    Positive_Control: Human tonsil, thymus or lymph node.

    Restrictions

    For Research Use only
  • Concentration

    1.0 mg/mL

    Buffer

    Prepared in 10 mM PBS, WITHOUT BSA and Azide.

    Agent conservateur

    Azide free

    Stock

    -20 °C,-80 °C

    Stockage commentaire

    Antibody without azide - store at -20 to -80 °C. Antibody is stable for 24 months. Non-hazardous.

    Date de péremption

    24 months
  • Antigène

    LY75/DEC-205 (LY75) (Lymphocyte Antigen 75 (LY75))

    Autre désignation

    LY75

    Sujet

    C-type lectin domain family 13 member B, CD205 antigen, CLEC13B, DEC205, gp200 MR6, LY75, Lymphocyte antigen 75, Renal Cell Carcinoma (gp200),CD205 / LY75 / DEC-205
    Cellular localisation: Cell surface

    Poids moléculaire

    198kDa

    ID gène

    4065, 100526664, 153563

    UniProt

    O60449
Vous êtes ici:
Chat with us!